zinc oxide

Phase 2Small molecule

UUniversity of Maryland, Baltimore

zinc oxide is one of 28 small molecule programs targeting Wound Healing. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Wound HealingActive, not recruiting

Wound HealingPhase 2

Active, not recruiting

Competition

Competitive Landscape

133 competitors in Wound Healing

#DrugCompanyPhaseTrials

Januvia

ZZydus Therapeutics Inc.

Phase 3

1 2

Avastin

BBio-Thera Solutions

Phase 3

1 3

Glucophage

EMD Serono

Phase 3

1 4

Growth Hormone

Pfizer

Phase 3

1 5

Vaseline

MMassachusetts General Hospital

Phase 3

1 6

Insulin Regular

TThe University of Texas Medical Branch, Galveston

Phase 3

1 7

Becaplermin

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 3

1 8

Nicorette

Pfizer

Preclinical

1 9

Zofran

Novartis

Preclinical

1 10

Restasis

TTaiwan Bio Therapeutics Inc.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Mebo1 trial

Zinc Oxide VS MEBO

Recruiting·KKing Abdullah Medical City·Phase 4·NCT07193849·76 enrolled

Wound Healing1 trial

The Effect of Donepezil on Wound Healing

Unknown status·UUniversity of Maryland, Baltimore·Phase 2·NCT04505670·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for zinc oxide. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — zinc oxide compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for zinc oxide. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Maryland, Baltimore company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: UUniversity of Maryland, Baltimore

zinc oxide

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Mebo1 trial

Wound Healing1 trial

References

Drug Info

Quick Facts

Related News